Indication · Neurology & Neurosurgery
Brain bleeding (hemorrhagic stroke)
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
61
Cleared or approved since 2000
PMA and De Novo
8
Higher-risk or first-of-kind devices
Breakthrough devices
3
Authorized through June 30, 2026
Recruiting device trials
41
177 device trials in all
Breakthrough-designated devices
- Annalise EnterpriseHarrison-AI Medical Pty, Ltd. · 2026
2 more devices with a free account
Devices
1 devices via De Novo. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- ContaCT
Viz.Al, Inc. · De Novo · Radiological Computer-Assisted Triage And Notification Software · newest 2018
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
- Comparative Study of Embolic Agents in Patients With Subdural Hemorrhage Undergoing Middle Meningeal Artery (MMA) EmbolizationNot yet recruiting
Sanford HealthAcademic, hospital or other
NCT07757113 · 30 participants (planned) · Start Mar 2027 · Primary completion Mar 2028
Device: Particles (polyvinyl alcohol or similar microspheres); Liquid Embolics (Onyx, n-BCA, or equivalent) and 1 more · For: Chronic Subdural Hematoma; Stroke; Middle Meningeal Artery Embolization
Sites: Sioux Falls, South Dakota
176 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on intracerebral hemorrhage across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.